Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOX1 | Q9Y5S8 | 8/20 | 0.38 |
| ▸ | GAA | P10253 | 8/20 | 0.37 |
| ▸ | MAPT | P10636 | 7/20 | 0.37 |
| ▸ | MEN1 | O00255 | 5/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.37 |
| ▸ | SNCA | P37840 | 2/20 | 0.37 |
| ▸ | CYBB | P04839 | 1/20 | 0.37 |
| ▸ | APP | P05067 | 1/20 | 0.37 |
| ▸ | NOX3 | Q9HBY0 | 1/20 | 0.37 |
| ▸ | NOX4 | Q9NPH5 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 4/20 | 0.36 |
| ▸ | NPC1 | O15118 | 4/20 | 0.36 |
| ▸ | RAB9A | P51151 | 4/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.36 |
| ▸ | MCL1 | Q07820 | 2/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.36 |
| ▸ | GFER | P55789 | 1/20 | 0.36 |
| ▸ | MAOB | P27338 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL563322 | 1.00 | NOX1 (0.38) | NOX1GAAMAPTMEN1KMT2A | |
| SCHEMBL436033 | 0.89 | NOX1 (0.41) | NOX1GAAMAPTMEN1KMT2A | |
| SCHEMBL563959 | 0.84 | GAA (0.42) | NOX1GAAMAPTMEN1KMT2A | |
| SCHEMBL433397 | 0.79 | MAPT (0.41) | NOX1GAAMAPTMEN1KMT2A | |
| SCHEMBL433232 | 0.77 | NOX1 (0.42) | NOX1GAAMAPTMEN1KMT2A | |
| SCHEMBL10370002 | 0.76 | GAA (0.48) | NOX1GAAMAPTMEN1KMT2A | |
| SCHEMBL434952 | 0.74 | SNCA (0.48) | NOX1GAAMAPTMEN1KMT2A | |
| SCHEMBL435356 | 0.74 | NOX1 (0.35) | NOX1GAAMAPTMEN1KMT2A | |
| SCHEMBL434961 | 0.74 | NOX1 (0.46) | NOX1GAAMAPTMEN1KMT2A | |
| SCHEMBL434466 | 0.74 | MAPT (0.46) | NOX1GAAMAPTMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11851685-B2 | Zwitterion buffer containing compositions and uses in electroanalytical devices and methods | ROCHE DIABETES CARE, INC. (US) | 2023-12-26 | — | — | US | claimed |
| US-20150330935-A1 | TEST DEVICE FOR ELECTROCHEMICAL ANALYSIS | ALERE TECHNOLOGIES LIMITED (GB) | 2015-11-19 | — | — | US | claimed |
| EP-2938602-A1 | TEST DEVICE FOR ELECTROCHEMICAL ANALYSIS | Alere Switzerland GmbH (CH) | 2015-11-04 | — | — | EP | claimed |
| WO-2014096407-A1 | TEST DEVICE FOR ELECTROCHEMICAL ANALYSIS | ALERE SWITZERLAND GMBH (CH) | 2014-06-26 | — | — | WO | claimed |
| EP-1867732-A1 | Reagents, methods and devices for detecting analytes | Bayer Corporation (US) | 2007-12-19 | — | — | EP | claimed |
| EP-1293574-B1 | Reagents, methods and devices for detecting analytes | BAYER CORP (US) | 2007-11-21 | — | — | EP | claimed |
| US-7163616-B2 | Reagents and methods for detecting analytes, and devices comprising reagents for detecting analytes | BAYER CORPORATION (US) | 2007-01-16 | — | — | US | claimed |
| US-20030094384-A1 | Reagents and methods for detecting analytes, and devices comprising reagents for detecting analytes | ASCENSIA DIABETES CARE HOLDINGS AG (CH) | 2003-05-22 | — | — | US | claimed |
| EP-1293574-A2 | Reagents, methods and devices for detecting analytes | Bayer Corporation (US) | 2003-03-19 | — | — | EP | claimed |
| EP-0747984-B1 | Mediators suitable for the electrochemical regeneration of NADH, NADPH or analogs thereof | BAYER AG (US) | 2002-08-14 | — | — | EP | claimed |
| EP-0747984-A2 | Mediators suitable for the electrochemical regeneration of NADH, NADPH or analogs thereof | Bayer Corporation (US) | 1996-12-11 | — | — | EP | claimed |
| US-5520786-A | ELECTRODE SURFACE HAS BEEN IMPARTED BY A MEDIATOR FUNCTION COMPRISING ONE OR MORE MEDIATOR COMPOUNDS SELECTED FROM SUBSTITUTED OR UNSUBSTITUTED 3-PHENYLIMINO-3H-PHENOTHIAZINES AND 3-PHENYLIMINO-3H-PHENOXAZINES | BAYER CORPORATION (US) | 1996-05-28 | — | — | US | claimed |
| US-11851685-B2 | Zwitterion buffer containing compositions and uses in electroanalytical devices and methods | ROCHE DIABETES CARE, INC. (US) | 2023-12-26 | — | — | US | disclosed |
| US-20220275348-A1 | ZWITTERION BUFFER CONTAINING COMPOSITIONS AND USES IN ELECTROANALYTICAL DEVICES AND METHODS | ROCHE DIABETES CARE, INC. | 2022-09-01 | — | — | US | disclosed |
| US-11180790-B2 | Reagents and methods for detecting analytes | ASCENSIA DIABETES CARE HOLDINGS AG (CH) | 2021-11-23 | — | — | US | disclosed |
| EP-3388824-B1 | METHODS OF DETECTING HIGH ANTIOXIDANT LEVELS DURING ELECTROCHEMICAL MEASUREMENTS AND FAILSAFING AN ANALYTE CONCENTRATION THEREFROM AS WELL AS DEVICES AND SYSTEMS INCORPORTING THE SAME | ROCHE DIABETES CARE GMBH (DE) | 2021-04-14 | — | — | EP | disclosed |
| EP-1293574-A2 | Reagents, methods and devices for detecting analytes | Bayer Corporation (US) | 2003-03-19 | — | — | EP | disclosed |
| EP-0747984-B1 | Mediators suitable for the electrochemical regeneration of NADH, NADPH or analogs thereof | BAYER AG (US) | 2002-08-14 | — | — | EP | disclosed |
| EP-0747984-A2 | Mediators suitable for the electrochemical regeneration of NADH, NADPH or analogs thereof | Bayer Corporation (US) | 1996-12-11 | — | — | EP | disclosed |
| US-5520786-A | ELECTRODE SURFACE HAS BEEN IMPARTED BY A MEDIATOR FUNCTION COMPRISING ONE OR MORE MEDIATOR COMPOUNDS SELECTED FROM SUBSTITUTED OR UNSUBSTITUTED 3-PHENYLIMINO-3H-PHENOTHIAZINES AND 3-PHENYLIMINO-3H-PHENOXAZINES | BAYER CORPORATION (US) | 1996-05-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150330935-A1 | TEST DEVICE FOR ELECTROCHEMICAL ANALYSIS | TES, FHIT, COXFA4L2 | NOX1 1015/4885GAA 1534/4885MAPT 727/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.